HK1214127A1 - 包含填充物质的生物可降解的微胶囊 - Google Patents

包含填充物质的生物可降解的微胶囊 Download PDF

Info

Publication number
HK1214127A1
HK1214127A1 HK16101050.7A HK16101050A HK1214127A1 HK 1214127 A1 HK1214127 A1 HK 1214127A1 HK 16101050 A HK16101050 A HK 16101050A HK 1214127 A1 HK1214127 A1 HK 1214127A1
Authority
HK
Hong Kong
Prior art keywords
filling material
microcapsules containing
biodegradable
containing filling
biodegradable microcapsules
Prior art date
Application number
HK16101050.7A
Other languages
English (en)
Chinese (zh)
Inventor
Kinam Park
Christopher A. Rhodes
Original Assignee
Akina, Inc.
Ohr Pharma, Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Akina, Inc., Ohr Pharma, Llc filed Critical Akina, Inc.
Publication of HK1214127A1 publication Critical patent/HK1214127A1/zh

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5021—Organic macromolecular compounds
    • A61K9/5031—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, poly(lactide-co-glycolide)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7028—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
    • A61K31/7034—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin
    • A61K31/704—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin attached to a condensed carbocyclic ring system, e.g. sennosides, thiocolchicosides, escin, daunorubicin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/167—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction with an outer layer or coating comprising drug; with chemically bound drugs or non-active substances on their surface
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4833—Encapsulating processes; Filling of capsules
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5089—Processes

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Ophthalmology & Optometry (AREA)
  • Molecular Biology (AREA)
  • Medicinal Preparation (AREA)
  • Cosmetics (AREA)
  • Dermatology (AREA)
HK16101050.7A 2012-09-20 2013-09-20 包含填充物质的生物可降解的微胶囊 HK1214127A1 (zh)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201261703723P 2012-09-20 2012-09-20
US61/703,723 2012-09-20
PCT/US2013/060922 WO2014047439A1 (en) 2012-09-20 2013-09-20 Biodegradable microcapsules containing filling material

Publications (1)

Publication Number Publication Date
HK1214127A1 true HK1214127A1 (zh) 2016-10-07

Family

ID=50341971

Family Applications (1)

Application Number Title Priority Date Filing Date
HK16101050.7A HK1214127A1 (zh) 2012-09-20 2013-09-20 包含填充物质的生物可降解的微胶囊

Country Status (9)

Country Link
US (3) US20150265541A1 (enExample)
EP (1) EP2897593A4 (enExample)
JP (2) JP2015532928A (enExample)
KR (1) KR20150090038A (enExample)
AU (3) AU2013317899A1 (enExample)
BR (1) BR112015006087A2 (enExample)
HK (1) HK1214127A1 (enExample)
MX (2) MX2015003665A (enExample)
WO (1) WO2014047439A1 (enExample)

Families Citing this family (42)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2011106702A2 (en) 2010-02-25 2011-09-01 The Johns Hopkins University Sustained delivery of therapeutic agents to an eye compartment
WO2012039979A2 (en) 2010-09-10 2012-03-29 The Johns Hopkins University Rapid diffusion of large polymeric nanoparticles in the mammalian brain
WO2012109363A2 (en) 2011-02-08 2012-08-16 The Johns Hopkins University Mucus penetrating gene carriers
AU2013209452B2 (en) 2012-01-19 2015-11-05 The Johns Hopkins University Nanoparticle formulations with enhanced mucosal penetration
HK1206270A1 (en) 2012-03-16 2016-01-08 The Johns Hopkins University Controlled release formulations for the delivery of hif-1 inhibitors
US10159743B2 (en) 2012-03-16 2018-12-25 The Johns Hopkins University Non-linear multiblock copolymer-drug conjugates for the delivery of active agents
WO2013166408A1 (en) 2012-05-03 2013-11-07 Kala Pharmaceuticals, Inc. Pharmaceutical nanoparticles showing improved mucosal transport
JP6360039B2 (ja) 2012-05-03 2018-07-18 カラ ファーマシューティカルズ インコーポレイテッド 複数の被覆された粒子を含む組成物、医薬組成物、医薬製剤、及び当該粒子の形成方法
US9827191B2 (en) 2012-05-03 2017-11-28 The Johns Hopkins University Compositions and methods for ophthalmic and/or other applications
US11596599B2 (en) 2012-05-03 2023-03-07 The Johns Hopkins University Compositions and methods for ophthalmic and/or other applications
WO2013166498A1 (en) 2012-05-04 2013-11-07 The Johns Hopkins University Lipid-based drug carriers for rapid penetration through mucus linings
WO2014124006A1 (en) 2013-02-05 2014-08-14 The Johns Hopkins University Nanoparticles for magnetic resonance imaging tracking and methods of making and using thereof
WO2015127368A1 (en) 2014-02-23 2015-08-27 The Johns Hopkins University Hypotonic microbicidal formulations and methods of use
KR20170106460A (ko) 2015-01-27 2017-09-20 더 존스 홉킨스 유니버시티 점막표면에서 활성제의 향상된 수송을 위한 저장성 하이드로겔 제제
WO2017035408A1 (en) 2015-08-26 2017-03-02 Achillion Pharmaceuticals, Inc. Compounds for treatment of immune and inflammatory disorders
AR106018A1 (es) 2015-08-26 2017-12-06 Achillion Pharmaceuticals Inc Compuestos de arilo, heteroarilo y heterocíclicos para el tratamiento de trastornos médicos
US20170273911A1 (en) * 2016-03-23 2017-09-28 Boston Scientific Scimed Inc. Injectable microspheres
EP3454856B1 (en) 2016-05-10 2024-09-11 C4 Therapeutics, Inc. Heterocyclic degronimers for target protein degradation
EP3455218A4 (en) 2016-05-10 2019-12-18 C4 Therapeutics, Inc. C3 CARBON-BASED GLUTARIMIDE DEGRONIMERS FOR TARGET PROTEIN REDUCTION
WO2017197051A1 (en) 2016-05-10 2017-11-16 C4 Therapeutics, Inc. Amine-linked c3-glutarimide degronimers for target protein degradation
WO2017197036A1 (en) 2016-05-10 2017-11-16 C4 Therapeutics, Inc. Spirocyclic degronimers for target protein degradation
JP7057290B2 (ja) 2016-06-27 2022-04-19 アキリオン ファーマシューティカルズ，インコーポレーテッド 医学的障害を治療するためのキナゾリン及びインドール化合物
WO2018005860A1 (en) 2016-07-01 2018-01-04 G1 Therapeutics, Inc. Pyrimidine-based antiproliferative agents
BR112019008475B1 (pt) * 2016-10-28 2022-06-07 Unilever Ip Holdings B.V. Composição para a higiene pessoal
CN109890363A (zh) 2016-10-28 2019-06-14 荷兰联合利华有限公司 包含表面改性颗粒和非挥发性官能化硅酮的个人护理组合物
DK3985002T3 (da) 2017-03-01 2025-08-18 Achillion Pharmaceuticals Inc Farmaceutiske aryl-, heteroaryl- og heterocyclylforbindelser til behandling af medicinske forstyrrelser
CN110769822A (zh) 2017-06-20 2020-02-07 C4医药公司 用于蛋白降解的n/o-连接的降解决定子和降解决定子体
WO2019191112A1 (en) 2018-03-26 2019-10-03 C4 Therapeutics, Inc. Cereblon binders for the degradation of ikaros
JP7538113B2 (ja) 2018-08-20 2024-08-21 アキリオン ファーマシューティカルズ，インコーポレーテッド 補体ｄ因子の医学的障害の治療のための医薬化合物
WO2020051532A2 (en) 2018-09-06 2020-03-12 Achillion Pharmaceuticals, Inc. Macrocyclic compounds for the treatment of medical disorders
CN113365617B (zh) 2018-10-16 2025-12-23 乔治亚州立大学研究基金会股份有限公司 用于医学疾病治疗的一氧化碳前药
WO2020149684A2 (ko) * 2019-01-18 2020-07-23 주식회사 대하맨텍 인체에 자극이 없어 안전하고 생분해가 가능한 캡슐 및 그의 제조방법
KR102272566B1 (ko) * 2019-01-18 2021-07-05 주식회사 대하맨텍 인체에 자극이 없어 안전하고 생분해가 가능한 캡슐 및 그의 제조방법
FR3091878B1 (fr) 2019-01-22 2023-06-16 Calyxia Compositions de produits d’entretien avec des propriétés olfactives améliorées
FR3091877B1 (fr) 2019-01-22 2023-06-16 Calyxia Compositions de detergence avec des propriétés olfactives améliorées
WO2020210805A1 (en) 2019-04-11 2020-10-15 The Johns Hopkins University Nanoparticles for drug delivery to brain
EA202192738A1 (ru) 2019-04-12 2022-03-17 С4 Терапьютикс, Инк. Трициклические соединения, обеспечивающие разрушение белка ikaros и белка aiolos
JP2023515073A (ja) 2020-02-20 2023-04-12 アキリオン ファーマシューティカルズ， インコーポレーテッド 補体因子ｄ媒介障害の処置用のヘテロアリール化合物
CN115279370B (zh) 2020-03-05 2025-01-10 C4医药公司 用于brd9的靶向降解的化合物
EP4652997A2 (en) 2020-05-19 2025-11-26 Pharmacosmos Holding A/s Cyclin-dependent kinase inhibiting compounds for the treatment of medical disorders
JP7787164B2 (ja) 2020-09-23 2025-12-16 アキリオン ファーマシューティカルズ， インコーポレーテッド 補体媒介性障害の治療のための医薬化合物
WO2024184188A1 (en) * 2023-03-03 2024-09-12 Danmarks Tekniske Universitet A method for preparing microparticles for drug delivery

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4001388A (en) * 1973-06-14 1977-01-04 Alza Corporation Ophthalmological bioerodible drug dispensing formulation
US4865846A (en) * 1988-06-03 1989-09-12 Kaufman Herbert E Drug delivery system
AU2001298061A1 (en) * 2000-12-13 2003-07-09 Purdue Research Foundation Microencapsulation of drugs by solvent exchange
US8425929B2 (en) * 2004-04-30 2013-04-23 Allergan, Inc. Sustained release intraocular implants and methods for preventing retinal dysfunction
JP2008520547A (ja) * 2004-10-04 2008-06-19 キューエルティー ユーエスエー，インコーポレイテッド． 眼部送達のためのポリマー送達処方
JP4856881B2 (ja) * 2005-02-01 2012-01-18 川澄化学工業株式会社 薬剤徐放システム
JP2009507845A (ja) * 2005-09-07 2009-02-26 サウスウエスト リサーチ インスティテュート 改良された放出速度を示す生分解性微粒子薬学的処方物
JP5201763B2 (ja) * 2007-02-28 2013-06-05 昇一 城武 異なる平均粒径サイズの粒子からなる混合微粒子カプセルの製造方法
US8071119B2 (en) * 2007-05-14 2011-12-06 Sustained Nano Systems Llc Controlled release implantable dispensing device and method
US8951567B2 (en) * 2007-09-27 2015-02-10 Akina, Inc. Sol-gel phase-reversible hydrogel templates and uses thereof
US20130316010A1 (en) * 2010-10-18 2013-11-28 Case Western Reserve University Polymeric microparticles

Also Published As

Publication number Publication date
MX2019002575A (es) 2019-10-30
KR20150090038A (ko) 2015-08-05
BR112015006087A2 (pt) 2017-07-04
JP2015532928A (ja) 2015-11-16
MX2015003665A (es) 2016-03-08
US20150265541A1 (en) 2015-09-24
AU2013317899A1 (en) 2015-05-07
WO2014047439A1 (en) 2014-03-27
EP2897593A1 (en) 2015-07-29
AU2018204552A1 (en) 2018-07-12
EP2897593A4 (en) 2016-04-06
US20180185296A1 (en) 2018-07-05
JP2019014729A (ja) 2019-01-31
US20200390715A1 (en) 2020-12-17
AU2020202735A1 (en) 2020-05-14
AU2013317899A8 (en) 2015-05-28

Similar Documents

Publication Publication Date Title
HK1214127A1 (zh) 包含填充物质的生物可降解的微胶囊
ZA201301242B (en) Containers and overwraps comprising thermoplastic polymer material,and related methods for making the same
ZA201500252B (en) Portion capsule having an identification on the inner periphery thereof
PL2394932T3 (pl) Kapsułka z osłabioną strefą zerwania
ZA201204718B (en) Substituted piperidines that increase p53 activity and the uses thereof
IL237101B (en) A secondary part, a system that includes a dental implant and the secondary part, and a package that includes the system
IL234815A0 (en) Heat-manufactured unbreakable pharmaceutical dosage form containing zinc
PT2868206T (pt) Micropartículas para o encapsulamento de probióticos, preparação e usos das mesmas
PL2895279T3 (pl) Dezynfekcja, sterylizacja i pakowanie produktów gotowych do spożycia
IL237068A (en) 1,3-dioxanomorphides and 1,3-dioxanocodides
EP3068442A4 (en) Bionanofluid for use as a contrast, imaging, disinfecting and/or therapeutic agent
LT2739615T (lt) Fenil-3-aza-biciklo[3.1.0]heks-3-il-metanonai ir jų panaudojimas kaip vaisto
ZA201209595B (en) N-acetyl-dl-leucine, neuroprotective and retinoprotective medicament
EP2687549A4 (en) Highly branched lipophilic polymer and photopolymerizable composition
ZA201703337B (en) Microcapsules containing a gas-generating photolabile polymer and uses thereof
EP3235517A4 (en) Deodorant, deodorant composition, and deodorizing product
IL236430A0 (en) Part of a capsule with identification on its circumference
SG2013095823A (en) Novel acryl monomer, polymer and resist composition comprising the same
BR112014029212A2 (pt) composição de agente de clarificação. composição de resina e artigo moldado
PT2895192T (pt) Uma composição farmacêutica compreendendo uma nanopartícula sólida e pelo menos um antígeno para o tratamento contra um agente patogénico intracelular
IL222137A (en) Extensive use protection device, intended in particular for syringes and the like
SG10201401301UA (en) Conjugated diene based polymer, and polymer composition containing the polymer
SG10201400572VA (en) Conjugated diene based polymer, and polymer composition containing the polymer
IL238788A0 (en) sema5b peptides and components containing them
SG10201400571XA (en) Conjugated diene based polymer, and polymer composition containing the polymer